SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001689375-24-000056
Filing Date
2024-09-30
Accepted
2024-09-30 16:32:11
Documents
1
Period of Report
2024-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1727728325.html 4  
1 FORM 4 wk-form4_1727728325.xml 4 3306
  Complete submission text file 0001689375-24-000056.txt   4839
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address
Dowden Nathan J (Reporting) CIK: 0001873392 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 241339894